Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Sonoran's lead product SBG003 (tobramycin and vancomycin hydrogel) has been granted Qualified Infectious Disease Product (QIDP) designation by the U.S. Food & Drug Administration (FDA) for prevention of post-abdominal surgical site infection.
Lead Product(s): Tobramycin,Vancomycin Hydrochloride
Therapeutic Area: Infections and Infectious Diseases Product Name: SBG003
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 03, 2020